Literature DB >> 6949607

High and low Fc IgG-receptor expression in human chronic granulocytic leukaemia cells.

A Harłozińska, J Potomski, B Lawinska, A Noworolska, R Richter.   

Abstract

Discontinuous density-gradient centrifugation was used to separate chronic granulocytic leukaemia (CGL) cells in the chronic phase and blast crisis (BC) into fractions containing granulocytes in individual stages of maturation. The occurrence of the Fc IgG (FcR) and complement-component receptors (CR1 and CR2) in each fraction was estimated. It was established that, with increasing yields of mature granulocytes, the proportion of cells bearing Fc and C3 receptors increased. The most important finding was that the high- and low-receptor categories of CGL cells in chronic phase depended on the percentage of FcR+ cells. In the high-receptor CGL group, in addition to FcR, the proportion of CR1+ and CR2+ cells was also greater than in the low-receptor CGL group. Some differences in clinical course of both immunological CGL groups were observed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6949607      PMCID: PMC2010893          DOI: 10.1038/bjc.1982.33

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes.

Authors:  S Gupta; R A Good; F P Siegal
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

2.  Immunologic characterization of chronic lymphocytic leukemia cells.

Authors:  T L Whiteside; A Winkelstein; B S Rabin
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

3.  Development of human granulocyte and monocyte Fc receptors.

Authors:  H A Herborn; H Valdimarsson; S N Wickramasinghe
Journal:  Scand J Haematol       Date:  1979-04-04

4.  Fc and C3 receptors as membrane differentiation markers of acute myelogenous leukaemia cells.

Authors:  A Harlozinska; J Potomski; A Noworolska; M Becker; R Richter
Journal:  Scand J Haematol       Date:  1980-09

5.  Separation and functional characterization of human neutrophil subpopulations.

Authors:  M S Klempner; J I Gallin
Journal:  Blood       Date:  1978-04       Impact factor: 22.113

6.  A new class of cell surface antigens. Quantitative absorption studies defining cell-lineage-specific antigens on hemopoietic cells.

Authors:  M V Berridge
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

7.  The sequential appearance of Ia-like antigens and two different complement receptors during the maturation of human neutrophils.

Authors:  G D Ross; C I Jarowski; E M Rabellino; R J Winchester
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

8.  Membrane receptors of mouse leukocytes. II. Sequential expression of membrane receptors and phagocytic capacity during leukocyte differentiation.

Authors:  E M Rabellino; G D Ross; H T Trang; N Williams; D Metcalf
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

9.  Patterns of maturation in short-term culture of human acute myeloid leukaemic cells.

Authors:  G Palú; R Powles; P Selby; B M Summersgill; P Alexander
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

  9 in total
  3 in total

1.  Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects.

Authors:  A Noworolska; A Harłozińska; F Buchegger; B Lawińska; R Richter
Journal:  Blut       Date:  1989-02

2.  Relationship between myelomonocytic, myeloid and nonspecific cross-reacting (NCA) antigens during myelocytic cell differentiation.

Authors:  A Harłozińska; A Noworolska; O Majdic; R Richter; S Kotlarek-Haus
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

3.  Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.

Authors:  A Noworolska; A Harłozińska; R Richter; W Brodzka
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.